ELLINGTON MANAGEMENT GROUP LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$823,000
+1.9%
3,000
-23.1%
0.22%
+286.0%
Q2 2018$808,000
-14.1%
3,900
-31.6%
0.06%
-16.2%
Q1 2018$941,000
+361.3%
5,700
+185.0%
0.07%
+21.4%
Q3 2016$204,000
+0.5%
2,000
+5.3%
0.06%
-35.6%
Q1 2016$203,000
-30.7%
1,900
-34.5%
0.09%
+20.8%
Q2 2015$293,000
+12.3%
2,900
-40.8%
0.07%
-17.2%
Q4 2014$261,000
-71.7%
4,900
-77.0%
0.09%
-50.0%
Q3 2013$922,00021,3000.17%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders